Partial Support in Chronic Heart Failure

Authors

Bart Meyns, Universitair Ziekenhuis Leuven (UZ Leuven), Leuven, BelgiumFollow
Walter Droogne, Universitair Ziekenhuis Leuven (UZ Leuven), Leuven, BelgiumFollow
Steven Jacobs, Universitair Ziekenhuis Leuven (UZ Leuven), Leuven, BelgiumFollow

Document Type

Brano Heart Failure Forum Proceedings Paper

Abstract

Partial left ventricular assist device (LVAD) support offers several advantages in treating chronic heart failure. It also raises concerns about insufficient support, worsening symptoms, and impediment of myocardial recovery. The clinical trial results for the CircuLite device (Medtronic) have shown that close monitoring can ensure improved outcomes for partial support. Another study on the ovine model demonstrated that partial and full support have similar effects regarding reverse remodeling. Thus, patients receiving partial LVAD support need regular follow-up care. Clinical assessment of symptoms and organ function must be used alongside objective judgment of patients’ needs to ensure support levels are appropriately adjusted.

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License

Recommended Citation

Meyns, Bart; Droogne, Walter; and Jacobs, Steven (2023) "Partial Support in Chronic Heart Failure," The VAD Journal: Vol. 9(1) :e2023916 DOI: https://doi.org/10.11589/vad/e2023916

Available at: https://digitalcommons.library.tmc.edu/vad/vol9/iss1/6

First Page

e2023916